Latest news
25 items- SECPetra Acquisition, Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits, Unregistered Sales of Equity Securities, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Change in Shell Company Status8-K - REVELATION BIOSCIENCES, INC. (0001810560) (Filer)
- SECPetra Acquisition, Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - REVELATION BIOSCIENCES, INC. (0001810560) (Filer)
- SECPetra Acquisition, Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits8-K - REVELATION BIOSCIENCES, INC. (0001810560) (Filer)
- INSIDERSEC Form 4: Feis Lawrence disposed of $7,465,890 worth of shares (731,950 units at $10.20)4 - Petra Acquisition Inc. (0001810560) (Issuer)
- 13D/GSEC Form SC 13G/A filed by Petra Acquisition, Inc. (Amendment)SC 13G/A - Petra Acquisition Inc. (0001810560) (Subject)
- NEWSEXCLUSIVE: New On NASDAQ Deck, Revelation Bio's COVID-19 Antiviral Shows Encouraging Preclinical ActionRevelation Biosciences Inc (NASDAQ:REVB) says that it observed a significant decrease in viral load with the prophylactic treatment of REVTx-99 in models of COVID-19 infection. What Happened: REVTx-99 was assessed for prophylactic antiviral activity against delta variant infection in three separate cell lines. Each cell line expressed sufficient levels of ACEII and TLR4, receptors required to sufficiently demonstrate viral infection as well as REVTx-99 activity, respectively. Why It Matters: Human primary bronchial/tracheal and alveolar epithelial cells were treated with 250 nanograms per mL (ng/mL) REVTx-99 one hour and 24 hours before infection, respectively. In both the cell lines, vi
- NEWSNew On NASDAQ Deck, Revelation Bio's COVID-19 Antiviral Shows Encouraging Preclinical ActionRevelation Biosciences Inc (NASDAQ:REVB) says that it observed a significant decrease in viral load with the prophylactic treatment of REVTx-99 in models of COVID-19 infection. What Happened: REVTx-99 was assessed for prophylactic antiviral activity against delta variant infection in three separate cell lines. Each cell line expressed sufficient levels of ACEII and TLR4, receptors required to sufficiently demonstrate viral infection as well as REVTx-99 activity, respectively. Why It Matters: Human primary bronchial/tracheal and alveolar epithelial cells were treated with 250 nanograms per mL (ng/mL) REVTx-99 one hour and 24 hours before infection, respectively. In both the cell lines, vi
- NEWSStocks That Hit 52-Week Lows On ThursdayOn Thursday, 615 stocks hit new 52-week lows. Noteable 52-Week Lows And Highs: Sea (NYSE:SE) is the largest company in terms of market cap to set a new 52-week low this morning. The smallest company by market cap to hit a new 52-week low was Reshape Lifesciences (NASDAQ:RSLS). Aligos Therapeutics (NASDAQ:ALGS) saw the largest move of the companies, as shares plummetted 46.75% to hit a new 52-week low. Vimeo (NASDAQ:VMEO) shares were the most resilient, as shares rose 0.0%, rebounding from its new 52-week low. The following stocks created new 52-week lows as of 10am on Thursday: Rivian Automotive (NASDAQ:RIVN) stock achieved a new 52-week low on Thursday morning, hitting $75
- NEWSStocks That Breached 52-Week Lows TodayStocks That Managed to Breach 52-Week Lows Tuesday Morning Before 10 am Tuesday, 44 stocks made new 52-week lows. 52-Week High And Low Highlights: Block (NYSE:SQ) was the biggest company on a market cap basis to set aStocks That Managed to Breach 52-Week Lows Tuesday Morning Before 10 am Tuesday, 44 stocks made new 52-week lows. 52-Week High And Low Highlights: Block (NYSE:SQ) was the biggest company on a market cap basis to set a new 52-week low. Shineco (NASDAQ:SISI) was the smallest company in terms of market cap to set a new 52-week low. Avrobio (NASDAQ:AVRO) made the largest move down on the session, with shares plummeting 36.88% to reach its 52-week low. Pathfinder Acquisition (NASDA
- SECPetra Acquisition, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits8-K - Petra Acquisition Inc. (0001810560) (Filer)
- SECSEC Form DEFA14A filed by Petra Acquisition, Inc.DEFA14A - Petra Acquisition Inc. (0001810560) (Filer)
- SECPetra Acquisition, Inc. filed SEC Form 8-K: Other Events8-K - Petra Acquisition Inc. (0001810560) (Filer)
- SECSEC Form 424B3 filed by Petra Acquisition, Inc.424B3 - Petra Acquisition Inc. (0001810560) (Filer)
- SECSEC Form EFFECT filed by Petra Acquisition, Inc.EFFECT - Petra Acquisition Inc. (0001810560) (Filer)
- SECSEC Form S-4/A filed by Petra Acquisition, Inc. (Amendment)S-4/A - Petra Acquisition Inc. (0001810560) (Filer)
- SECSEC Form S-4/A filed by Petra Acquisition, Inc. (Amendment)S-4/A - Petra Acquisition Inc. (0001810560) (Filer)
- SECSEC Form DEFA14A filed by Petra Acquisition, Inc.DEFA14A - Petra Acquisition Inc. (0001810560) (Filer)
- SECPetra Acquisition, Inc. filed SEC Form 8-K: Other Events8-K - Petra Acquisition Inc. (0001810560) (Filer)
- SECSEC Form S-4/A filed by Petra Acquisition, Inc. (Amendment)S-4/A - Petra Acquisition Inc. (0001810560) (Filer)
- INSIDERSEC Form 3: New insider Feis Lawrence claimed ownership of 746,491 shares3 - Petra Acquisition Inc. (0001810560) (Issuer)
- SECSEC Form 425 filed by Petra Acquisition, Inc.425 - Petra Acquisition Inc. (0001810560) (Subject)
- SECSEC Form 10-Q filed by Petra Acquisition, Inc.10-Q - Petra Acquisition Inc. (0001810560) (Filer)
- SECSEC Form 425 filed by Petra Acquisition, Inc.425 - Petra Acquisition Inc. (0001810560) (Subject)
- SECPetra Acquisition, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - Petra Acquisition Inc. (0001810560) (Filer)
- SECPetra Acquisition, Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Petra Acquisition Inc. (0001810560) (Filer)
PAIC FAQ
6 questionsWhat does Petra Acquisition, Inc. do?
Petra Acquisition, Inc. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2019 and is based in New York, New York.Where does PAIC stock trade?
Petra Acquisition, Inc. (PAIC) is listed on NASDAQ.What sector and industry is PAIC in?
Petra Acquisition, Inc. operates in the Finance sector, Business Services industry.When did Petra Acquisition, Inc. go public?
Petra Acquisition, Inc. (PAIC) completed its IPO in 2020.What companies are similar to PAIC?
Notable peers in the same industry include FLT (FleetCor Technologies Inc.), NVEI (Nuvei Corporation Subordinate Voting Shares), NLSN (Nielsen N.V.), STMP (Stamps.com Inc.), ENV (Envestnet Inc). Compare PAIC side-by-side with any of them on Quantisnow.How can I track PAIC on Quantisnow?
Quantisnow aggregates Petra Acquisition, Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PAIC to receive live email and push alerts on every new disclosure.